Skip to main content
MITI
OTC Technology

Mitesco Files 10-K: Going Concern Warning, Massive Dilution Risk, and Weak Internal Controls Highlighted

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.11
Mkt Cap
$1.905M
52W Low
$0.041
52W High
$0.599
52W Position info
167% above low
Off High info
82% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

MITI has more than doubled off its 52-week low of $0.041.

Summary

Mitesco's 10-K discloses a going concern warning, significant operational losses, and material weaknesses in internal controls, alongside massive potential dilution from preferred stock and new highly dilutive convertible debt.


Key Events · Financing and Capital Events · MITI

  • Substantial Doubt About Going Concern

    Both management and the independent auditor have expressed substantial doubt about Mitesco's ability to continue as a going concern due to recurring operating losses and insufficient liquidity.

  • Significant Dilution Risk from Preferred Stock

    The company's Series A Preferred Stock, if fully redeemed into common stock, could result in the issuance of 88,890,000 shares, representing over 400% dilution to the 20,776,179 common shares outstanding as of April 13, 2026.

  • New Highly Dilutive Convertible Notes

    Mitesco secured a $50,000 convertible promissory note on April 10, 2026, with conversion terms at the lesser of $0.15 per share or 65% of the lowest trading price over the prior ten days, indicating distressed financing.

  • Material Weaknesses in Internal Controls

    Management identified material weaknesses in internal controls over financial reporting, including a lack of segregation of duties and insufficient accounting resources, rendering controls ineffective as of December 31, 2025.


Analysis · MITI · Technology

Mitesco, Inc.'s annual report reveals severe financial distress, with both management and the independent auditor expressing substantial doubt about the company's ability to continue as a going concern. Despite reporting a net income, this was driven by a non-cash revaluation of derivative liabilities, not operational profitability, as revenues remain minimal and operating losses increased. The company faces extreme dilution risk from its Series A Preferred Stock, which could result in over 400% dilution if fully converted, and has recently entered into new highly dilutive convertible notes with variable conversion prices. Furthermore, material weaknesses in internal controls over financial reporting raise significant concerns about the reliability of its financial statements. Investors should be aware of the company's precarious financial position and the substantial dilution threat.

At the time of this filing, MITI was trading at $0.11 on OTC in the Technology sector, with a market capitalization of approximately $1.9M. The 52-week trading range was $0.04 to $0.60. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MITI - Latest Insights

MITI
Jul 21, 2026, 5:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0975
Real-time Price: $0.049 info
Change: -$0.0485 (-50%) info
Market Cap: $1.026M info
MITI
Jul 09, 2026, 4:13 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.070
Real-time Price: $0.049 info
Change: -$0.021 (-30%) info
Market Cap: $1.026M info
MITI
Jul 02, 2026, 7:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.075468
Real-time Price: $0.049 info
Change: -$0.026468 (-35%) info
Market Cap: $1.026M info
MITI
Jun 30, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.073
Real-time Price: $0.049 info
Change: -$0.024 (-33%) info
Market Cap: $1.026M info
MITI
Jun 08, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.085
Real-time Price: $0.049 info
Change: -$0.036 (-42%) info
Market Cap: $1.026M info